Lpl Financial LLC Lipocine Inc. Transaction History

Lpl Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.3 - $0.58 $1,500 - $2,900	-5,000 Reduced 8.13%	56,500 $18,000
Q4 2022 Feb 07, 2023	SELL	$0.37 - $8.65 $462 - $10,812	-1,250 Reduced 1.99%	61,500 $24,000
Q2 2022 Aug 12, 2022	SELL	$0.73 - $1.34 $5,475 - $10,050	-7,500 Reduced 10.68%	62,750 $50,000
Q1 2022 May 16, 2022	BUY	$0.89 - $1.85 $6,675 - $13,875	7,500 Added 11.95%	70,250 $96,000
Q2 2021 Aug 13, 2021	BUY	$1.17 - $1.59 $23,400 - $31,800	20,000 Added 46.78%	62,750 $88,000
Q1 2021 May 14, 2021	BUY	$1.38 - $2.28 $690 - $1,140	500 Added 1.18%	42,750 $65,000
Q2 2020 Aug 13, 2020	BUY	$0.42 - $1.26 $17,745 - $53,235	42,250 New	42,250 $53,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $335M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.